Drug Shortage Report for SEPTA-ZOLMITRIPTAN-ODT
Report ID | 14082 |
Drug Identification Number | 02428474 |
Brand name | SEPTA-ZOLMITRIPTAN-ODT |
Common or Proper name | Zolmitriptan Orally Disintegrating tablets |
Company Name | SEPTA PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | ZOLMITRIPTAN |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 6s |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-06-27 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-08-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7035 MAXWELL ROAD, UNIT # 2 MISSISSAUGA, ONTARIO CANADA L5S 1R5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-27 | English | Compare |
v2 | 2017-06-27 | English | Compare |
v3 | 2017-06-27 | English | Compare |
v4 | 2017-06-27 | English | Compare |
v5 | 2017-06-27 | English | Compare |
v6 | 2017-06-27 | French | Compare |
v7 | 2017-06-28 | English | Compare |
v8 | 2018-02-26 | English | Compare |
v9 | 2018-02-26 | French | Compare |
v10 | 2018-04-18 | English | Compare |
v11 | 2018-04-18 | French | Compare |
v12 | 2018-12-17 | English | Compare |
v13 | 2018-12-17 | French | Compare |
v14 | 2019-08-01 | English | Compare |
Showing 1 to 14 of 14